Session Details

S039 Dermatologic Surgery: Cosmetic Tips and Pearls

Sat, Mar 8, 1:00 PM - 4:00 PM
W314B
3 CME Available Symposium Restricted
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Cosmetic tips and pearls will be presented to enhance treatment options for the best cosmetic results. Topics covered will include surgery, lasers and other machines, fillers, botulinum toxins, peels, etc. New techniques and pearls will be presented to make patient treatments more efficacious.

LEARNING OBJECTIVES

1.

Evaluate patients for the best cosmetic treatments.

2.

Choose the most appropriate treatment for each patient.

SCHEDULE

6:00 PM

TBD

SPEAKERS

Vince Bertucci, MD, FAAD

Vince Bertucci, MD, FAAD

Harold J. Brody, MD, FAAD

Harold J. Brody, MD, FAAD

Anne M. Chapas, MD, FAAD

Anne M. Chapas, MD, FAAD

Sabrina G. Fabi, MD, FAAD

Sabrina G. Fabi, MD, FAAD

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

Omar Ibrahimi, MD, PhD, FAAD

Omar Ibrahimi, MD, PhD, FAAD

Kavita Mariwalla, MD, FAAD

Kavita Mariwalla, MD, FAAD

Gary D. Monheit, MD, FAAD

Gary D. Monheit, MD, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Rhoda S. Narins, MD, FAAD

Rhoda S. Narins, MD, FAAD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

SPEAKER DISCLOSURES

Vince Bertucci, MD, FAAD

Allergan, Inc – Consultant (1099 relationship)(Fees); Allergan, Inc. – Advisory Board(Fees), Investigator(Fees), Speaker(Honoraria); AMNI Aesthetic Medicine Network Inc. – Consultant(Honoraria), Stockholder Private Company(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Clarion Medical Technologies – Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); Galderma Canada, Inc – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Fees); Galderma USA – Investigator(Fees); L'Oreal – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Fees); Revance Therapeutics, Inc. – Advisory Board(Fees); TEOXANE Laboratories – Speaker(Fees);

Harold J. Brody, MD, FAAD

No financial relationships exist with ineligible companies.

Anne M. Chapas, MD, FAAD

Allergan, Inc – Speaker/Faculty Education(Honoraria); Cytrellis Biosystems, Inc – Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); InMode MD Ltd – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); lutronic – Speaker(Honoraria); Revance – Investigator(Grants/Research Funding); reveance – Investigator(Grants/Research Funding); sofwave – Speaker(Honoraria); Solta Medical – Speaker(Honoraria); Syneron Candela – Advisory Board(Honoraria);

Sabrina G. Fabi, MD, FAAD

AbbVie – Advisory Board(Honoraria), Investigator(Honoraria), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Investigator(Honoraria); Endo International plc – Investigator(Grants/Research Funding); Galderma – Investigator(Honoraria), Speaker/Faculty Education(Honoraria); Merz Aesthetics – Investigator(Honoraria), Speaker/Faculty Education(Honoraria); Revance – Speaker(Honoraria), Stockholder Private Company(Honoraria); symatese – Investigator(Honoraria); TEOXANE Laboratories – Investigator(Honoraria);

Roy G. Geronemus, MD, FAAD

Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);

Omar Ibrahimi, MD, PhD, FAAD

AbbVie – Stockholder(Stock); Accure, Inc – Advisory Board(No Compensation Received); Acure Acne – Stockholder(Stock); Allergan, Inc – Advisory Board(Honoraria); AVAVA, LLC – Investigator(Grants/Research Funding); Beam Therapeutics – Stockholder(Stock); CRISPR Therapeutics – Stockholder(Stock); Cutera, Inc. – Speaker(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria); Editas Medicine – Stockholder(Stock); Gingko Bioworks Holding Inc – Stockholder(Stock); Intellia Therapeutics – Stockholder(Stock); Lutronic – Advisory Board(Honoraria); Moderna Therapeutics – Stockholder(Stock); Pfizer Inc. – Stockholder(Stock); Procter & Gamble Company – Stockholder(Stock); Revance Therapeutics, Inc. – Stockholder(Stock); Unilever – Stockholder(Stock); Vertex Pharmaceuticals, Inc. – Stockholder(Stock);

Kavita Mariwalla, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); BelleTorus Corporation – Stockholder(Stock Options); Boards University – Founder(Honoraria); Galderma USA – Advisory Board(Fees); L'Oreal USA Inc. – Consultant(Fees); Merz Aesthetics – Investigator(Grants/Research Funding); Neutrogena Corporation – Other(Honoraria); Skinfix, Inc. – Consultant(Fees); Unilever – Other(Honoraria);

Gary D. Monheit, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Grants/Research Funding); Hugel – Advisory Board(Honoraria); Merz Pharmaceuticals, LLC – Consultant(Honoraria); Revance Therapeutics, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sienna Biopharmaceuticals – Investigator(Grants/Research Funding); Suneva Medical, Inc. – Consultant(No Compensation Received), Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding);

Girish S. Munavalli, MD, MHS, FAAD

AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);

Rhoda S. Narins, MD, FAAD

No financial relationships exist with ineligible companies.

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);